COMP <GO>
HCSG vs ABBV // EV/EBITDA & P/E VALUATION
Healthcare Services Group Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: HCSG 3
— ABBV 6
■ METRIC PARITY
LAST: $24.68 (+2.58%) • MKT CAP: $1.66B
valuation
—
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
valuation
33.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HCSG VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HCSG | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 13.00% | 70.20% | -57.20 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.60% | 29.00% | -17.40 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.36% | 3.47% | +4.89 | HCSG | /fcf-yield <GO> |
| Operating Margin | — | 24.60% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 6.90% | -3.70 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 7.10% | 8.60% | -1.50 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.33 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.3 | 65.1 | +2.20 | HCSG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.2x | 113.1x | -86.90 | HCSG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.66B | $513.86B | -$512.20B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HCSG REV | ABBV REV | HCSG GROSS % | ABBV GROSS % | HCSG FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.84B | $61.16B | 13.0% | 70.2% | $139.2M | $17.82B |
| FY 2024 | $1.72B | $56.33B | 13.3% | 70.0% | $24.5M | $17.83B |
| FY 2023 | $1.67B | $54.32B | — | — | $43.5M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HCSG // BETA —
ABBV // BETA 1.15